NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









The Insides Company

The Insides Company

Private
AucklandHealthcare & Life Scienceshttps://www.theinsides.co/

Last Round

Series A

Extension

Mar 31, 2023

Est. Valuation

$17.61M

Total Funding Raised

$9.43M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

The Insides Company is a medical technology company that develops and manufactures innovative medical devices for chyme reinfusion therapy to treat patients with severe intestinal failure.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

chyme reinfusionchyme reinfusion therapyCRTintestinal failuremedical deviceenterocutaneous fistulaostomy managementparenteral nutrition alternativegut health techmedtechgastrointestinal deviceclinical nutritionmedical consumables

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

The Insides Company Comps

Public and private peers based on sector, stage, and business model.

The Insides Company comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

The Insides Company Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMar 31, 2023
Series AAug 10, 2021
AngelJun 1, 2019

Key People

Founding team and executive leadership

Robert Davidson

Co-Founder, CTO, Director

Founding Team

Garth Sutherland

CEO

Executive Team

John Davidson

Director, COO

Executive Team

The Insides Company Investors

Notable investors and investment history

The Insides Company investors
InvestorRounds
Icehouse VenturesAngel
Snowball EffectSeries A Extension
K1W1Angel
Auckland UniServices LimitedAngel
New Zealand Growth Capital PartnersAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors increased 35% MoM, reaching 7.3K.

  • Jul 6, 2025

    Monthly visitors grew 93% MoM.

The Insides Company Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

The Insides Company Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about The Insides Company's valuation, stock price, and market status.

Firmographic Details

HeadquartersAuckland
Employee Range14
Year Founded2017
Last FundingMar 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.